How would that analysis change if we (optimistically) assume that in 2 years, we have a vaccine that's 90% effective? I would assume that under that scenario,

How would that analysis change if we (optimistically) assume that in 2 years, we have a vaccine that's 90% effective? I would assume that under that scenario, the backlog would disappear shortly after the 2-year mark.